Search hospitals > California > Stanford
Stanford Hospital and Clinics
Claim this profileStanford, California 94305
Global Leader in Breast Cancer
Global Leader in Leukemia
Conducts research for Cancer
Conducts research for Lymphoma
Conducts research for Tumors
179 reported clinical trials
20 medical researchers
Summary
Stanford Hospital and Clinics is a medical facility located in Stanford, California. This center is recognized for care of Breast Cancer, Leukemia, Cancer, Lymphoma, Tumors and other specialties. Stanford Hospital and Clinics is involved with conducting 179 clinical trials across 410 conditions. There are 20 research doctors associated with this hospital, such as Andrei Iagaru, MD, David P. Lee, MD, Seema Nagpal, MD, and Jack Boyd, MD.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
Stage III
2Leukemia
Global LeaderTop PIs
Andrei Iagaru, MDStanford University, School of Medicine7 years of reported clinical research
Studies Adenocarcinoma
Studies Prostate Cancer
14 reported clinical trials
20 drugs studied
David P. Lee, MDStanford Hospital and Clinics6 years of reported clinical research
Studies High Blood Pressure
Studies Vascular Disease
10 reported clinical trials
15 drugs studied
Seema Nagpal, MDStanford Cancer Institute2 years of reported clinical research
Studies Glioblastoma
Studies Solid Tumors
10 reported clinical trials
13 drugs studied
Jack Boyd, MDStanford University5 years of reported clinical research
Studies Mitral Valve Regurgitation
Studies Stroke
6 reported clinical trials
10 drugs studied
Clinical Trials running at Stanford Hospital and Clinics
Breast Cancer
Multiple Myeloma
Pulmonary Fibrosis
Lymphoma
Chronic Kidney Disease
Mitral Valve Regurgitation
Fibrosis
Colorectal Cancer
Prostate Cancer
Abdominal Aortic Aneurysm
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
High-Dose Abemaciclib
for Early-Stage Breast Cancer
This trial is testing if adjusting the dose of abemaciclib, along with hormone treatments, will cause fewer side effects and be easier for patients with early-stage high-risk hormone receptor positive breast cancer to handle. The treatment works by blocking proteins and hormones that help cancer grow. Abemaciclib has shown potential in improving survival outcomes and quality of life in patients with advanced hormone receptor-positive breast cancer.
Recruiting1 award Phase 216 criteria
T-DM1 vs TH
for Breast Cancer
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stanford Hospital and Clinics?
Stanford Hospital and Clinics is a medical facility located in Stanford, California. This center is recognized for care of Breast Cancer, Leukemia, Cancer, Lymphoma, Tumors and other specialties. Stanford Hospital and Clinics is involved with conducting 179 clinical trials across 410 conditions. There are 20 research doctors associated with this hospital, such as Andrei Iagaru, MD, David P. Lee, MD, Seema Nagpal, MD, and Jack Boyd, MD.